Search
Close this search box.

Lexogen NGS Services

Where NGS experts provide you with first-class solutions

Our Successes

What our customers say about us

What Lexogen NGS Services has accomplished so far

Extensive expertise and years of experience have positioned us as the leading NGS service provider for non-standard projects and complex challenges. We excel at working with diverse RNA input, be it low concentration, compromised quality, or sample-unique inputs. We navigate essential project requirements and adapt our workflows to perfectly align with your specific goals and to ensure the project’s success and maximized outcomes.
Icon_35_Challenging Materials

Specialist for Challenging Material

We routinely process low-input, degraded, or the trickiest samples from FFPE, blood or directly from lysates.
Icon_36_Customer in Focus

Customer in Focus

We believe only a tailored approach leads to success and what we all want: best-quality data.
Icon_37_NGS Development

Trusted NGS Development Partner

We enable scale-up and support workflow development and implementation for maximized growth.
Icon_38_Customer Satisfaction

Highest Customer Satisfaction

We always go the extra mile and deliver on our commitments - this is being acknowledged, thank you!

Where we excel and set us apart

Case Studies

High-quality data is the foundation of advanced discoveries using transcriptomics. Lexogen NGS Services delivers the precision required for deep biological insights, as demonstrated by these impactful collaborations with our global partners.

We have processed various species and offer streamlined analysis for

Cow_Species

Cow (Bos taurus)

Dog_Species

Dog (Canis lupus familiaris)

Goat_Species

Goat (Capra hircus)

Cat_Species

Cat (Felis catus)

Human-family_Species

Human (Homo sapiens)

Mouse_Species

Mouse (Mus musculus)

Rabbit_Species

Rabbit (Oryctolagus cuniculus)

Rat_Species

Rat (Rattus norvegicus)

Pig__Species

Pig (Sus scrofa)

Arabidopsis_Species

Arabidopsis
(Arabidopsis thaliana & halleri)

Purple false brome__Species

Purple false brome
(Brachypodium distachyon)

African Oil Palm_Species

African Oil Palm
(Elaeis guineensis)

Barley_Species

Barley (Hordeum vulgare)

Rice_Species

Rice (Oryza sativa)

Tomato_Species

Tomato (Solanum lycopersicum)

Potato_Species

Potato (Solanum tuberosum)

Sorghum_Species

Sorghum (Sorghum bicolor)

Cacao Tree_Species

Cacao Tree
(Theobroma cacao criollo)

Maize-Corn_Species

Maize / Corn (Zea mays)

Zebrafish_Species

Zebrafish (Danio rerio)

Rainbow Trout_Species

Rainbow Trout
(Oncorhynchus mykiss)

Salmon_Species

Salmon (Salmo salar)

Painted Turtles_Species

Painted Turtles
(Chrysemys picta bellii)

Drosophila melanogaster_Species

Drosophila melanogaster

Drosophila melanogaster_Species

Chicken (Gallus gallus)

Bartonella henselae

Bartonella henselae

COVID19 (SARS-CoV-2)_Species

COVID19 (SARS-CoV-2)

Pseudomonas aeruginosa_Species

Pseudomonas aeruginosa

Caenorhabditis elegans_Species

Caenorhabditis elegans

Fungus (Fusarium oxysporum)

Saccharomyces cerevisiae_Species

Baker’s Yeast
(Saccharomyces cerevisiae)

A Track Record of our Drug Discovery Milestones

At Lexogen, we successfully realize services projects throughout the drug discovery and development process and have contributed to the advancements of numerous promising therapies. Some exemplary case studies of our greatest achievements:
Early Drug Discovery
  • Target identification & validation on FFPE samples or mammalian cell lines
  • Disease-associated pathway identification using SLAMseq
Lead Discovery
  • In-parallel RNA-Seq screening of RNA therapeutics in cell assays with more than 100,000 samples
  • High-throughput Pathway Analysis in various cancer models
  • Dose-response studies & pathway associations using dose-dependent RNA-Seq
  • Transcript-wide evaluation of siRNA validity in RNA therapeutics
  • RNA structural analysis (Shape-Seq) on full-length RNA and small RNA
Pre-clinical Studies
  • Identifying primary and secondary drug targets by Kinetic RNA-Seq & pathway activation sequence
  • Biomarker discovery, e.g., of small RNAs in extracellular vesicles (EVs)
Clinical Trials
  • Immune Profiling of PBMCs by BCR/ TCR-Seq with integrated V(D)J for TCR clonotypes
Post-market Research
  • Drug repurposing and combinational therapeutics expression profiling
  • In silico drug repurposing using AI models

Webinars

In our webinar “Deep Phenotyping of the Human Liver for NAFLD (NASH) Target Discovery”, Dr. Quin Wills, CSO of Ochre Bio, highlights how AI facilitates target discovery for chronic liver diseases and how Lexogen NGS Services was instrumental in successfully addressing common challenges of working with biobanked FFPE samples.

Ready to be part of the success story?

Get in touch with our PhD-level RNA experts and explore the possibilities for your next project.

Together we will pinpoint the ideal solution, carefully considering all your unique needs.

We look forward to collaborating!

Cart

Product

Product Short Description
PRICE

Product

Product Short Description
PRICE

Product

Product Short Description
PRICE

My Account

Login

Register